ASEPCO Opens New California Facility
The new site will provide employees with more space, enhanced R&D facilities, and a fully functional sanitary products training center.
ASEPCO, a Watson-Marlow Fluid Technology Group bioprocessing applications manufacturing company, announced the opening of its new facility in Milpitas, CA, for expanded research and warehouse space.
The new site will provide employees with more space, enhanced R&D facilities, and a fully functional sanitary products training center, according to a Sept. 23, 2019 press release.
“We are delighted to be moving into our new expanded facility,” said Bill Mandel, president of ASEPCO, in the press release. “ASEPCO is committed to providing the highest quality bioprocessing valves. This move will enable us to enhance the services we offer and with our new state-of-the-art R&D facilities, to continue to develop the best products for all our customers’ biotechnology and pharmaceutical applications.”
Source: ASEPCO
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
